1,175
Views
0
CrossRef citations to date
0
Altmetric
Research Article

“More drugs means more stress on my body”: exploring enhancement and health among elite strength athletes who use performance and image enhancing drugs

, , &
Received 21 Jul 2023, Accepted 13 Oct 2023, Published online: 23 Oct 2023

References

  • Adams P. 2006. Exploring social constructivism: theories and practicalities. Education. 34(3):243–257. doi: 10.1080/03004270600898893.
  • Alexander DM, Hutt EA, Lefebvre JS, Bloom GA. 2019. Using imagery to enhance performance in powerlifting: a review of theory, research, and practice. Strength Cond J. 41(6):102–109. doi: 10.1519/SSC.0000000000000490.
  • Braun V, Clarke V. 2019. Reflecting on reflexive thematic analysis. Qual Res Sport Exer Health. 11(4):589–597. doi: 10.1080/2159676X.2019.1628806.
  • Braun V, Clarke V. 2021. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qual Res Psycho. 18(3):328–352. doi: 10.1080/14780887.2020.1769238.
  • Braun V, Clarke V. 2023. Toward good practice in thematic analysis: avoiding common problems and be (com) ing a knowing researcher. Int J Transgend Health. 24(1):1–6. doi: 10.1080/26895269.2022.2129597.
  • Delanda M. 2019. A new philosophy of society: assemblage theory and social complexity. London, U.K: Bloomsbury Publishing.
  • Duff C. 2005. Party drugs and party people: examining the ‘normalization’of recreational drug use in Melbourne, Australia. Int J Drug Policy. 16(3):161–170. doi: 10.1016/j.drugpo.2005.02.001.
  • Duff C. 2007. Towards a theory of drug use contexts: space, embodiment and practice. Addict Res Theory. 15(5):503–519. doi: 10.1080/16066350601165448.
  • Duff C. 2011. Networks, resources and agencies: on the character and production of enabling places. Health Place. 17(1):149–156. doi: 10.1016/j.healthplace.2010.09.012.
  • Duff C. 2012. Accounting for context: exploring the role of objects and spaces in the consumption of alcohol and other drugs. Soc Cult Geogr. 13(2):145–159. doi: 10.1080/14649365.2012.655765.
  • Duff C. 2014. The place and time of drugs. Int J Drug Policy. 25(3):633–639. doi: 10.1016/j.drugpo.2013.10.014.
  • Dunn M, Piatkowski T. 2021. Investigating the impact of COVID-19 on performance and image enhancing drug use. Harm Reduct J. 18(1):124. doi: 10.1186/s12954-021-00571-8.
  • Foucault M. 1985. La vie: l‘expérience et la science. Revue De Métaphysique Et De Morale. 90(1):3–14.
  • Foucault M. 1988. Technologies of the self. In: Martin LH, Gutman H, Hutton PH, editors. Technologies of the self: a seminar with Michel Foucault. Amherst: Univ. Mass. Press; p. 16–49.
  • Gibbs N, Cox L, Turnock L. 2022. Anabolics coaching: emic harm reduction or a public health concern? Perform Enhanc Health. 10(3):100227. doi: 10.1016/j.peh.2022.100227.
  • Gibbs N, Piatkowski T. 2023. The Liver King Lie: misrepresentation, justification, and public health implications. Int J Drug Policy. 114:103979. doi: 10.1016/j.drugpo.2023.103979.
  • Hearne E, Wazaify M, Van Hout MC, Atkinson A, McVeigh J. 2021. Anabolic-androgenic steroid use in the Eastern Mediterranean region: a scoping review of extant empirical literature. Int J Ment Health Addict. 19(4):1162–1189. doi: 10.1007/s11469-019-00217-8.
  • Hope V, Underwood M, Mulrooney K, Mazanov J, van de Ven K, McVeigh J. 2021. Human enhancement drugs: emerging issues and responses. Int J Drug Policy. 95:103459. doi: 10.1016/j.drugpo.2021.103459.
  • Jackson P. 2004. Inside clubbing: sensual experiments in the art of being human. New York: Bloomsbury Academic.
  • Jokipalo I, Khudayarov A. 2021. A Netnography and a survey on doping use among competitive doping-untested strength-sport athletes. Int J Sports Med. 42(7):645–650. doi: 10.1055/a-1342-7312.
  • Kanayama G, Pope HG. 2018. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 464:4–13. doi: 10.1016/j.mce.2017.02.039.
  • Kimiecik JC, Jackson SA. 2002. Optimal experience in sport: a flow perspective. In T. S. Horn (Ed.), Advances in sport psychology. Champaign (IL): Human Kinetics; p. 501–527.
  • Lemiński A, Kubis M, Kaczmarek K, Gołąb A, Kazimierczak A, Kotfis K, Słojewski M. 2022. When bodybuilding goes wrong—bilateral renal artery thrombosis in a long-term misuser of anabolic steroids treated with angiojet rheolytic thrombectomy. Int J Environ Res Public Health. 19(4):2122. doi: 10.3390/ijerph19042122.
  • Moore D. 2004. Drugalities: the generative capabilities of criminalized ‘drugs’. Int J Drug Policy. 15(5–6):419–426. doi: 10.1016/j.drugpo.2004.06.008.
  • Moore JL, Travis SK, Lee ML, Stone MH. 2019. Making weight: maintaining body mass for weight class barbell athletes. J Strength Cond. 41(6):110–114. doi: 10.1519/SSC.0000000000000503.
  • Piatkowski TM, Hides LM, White KM, Obst PL, Dunn M. 2022a. Understanding perspectives on harm reduction from performance and image enhancing drug consumers and health care providers. Perform Enhanc Health. 10(3):100223. doi: 10.1016/j.peh.2022.100223.
  • Piatkowski TM, Obst PL, White KM, Hides LM. 2022b. The relationship between psychosocial variables and drive for muscularity among male bodybuilding supplement users. Australian Psychologist. 57(2):148–159. doi: 10.1080/00050067.2021.2020074.
  • Piatkowski T, Lamon S, Robertson J, Dunn M. 2023a. Gendered perspectives on women’s anabolic-androgenic steroid (AAS) usage practices. Harm Reduct J. 20(1):56. doi: 10.1186/s12954-023-00786-x.
  • Piatkowski TM, Neumann DL, Dunn M. 2023b. “My Mind Went to Mush”: a qualitative exploration of trenbolone use among the performance and image enhancing drug community. Drug & Alcohol Review. 42(6):1566–1576. doi: 10.1111/DAR.13656.
  • Piatkowski T, Puljevic C, Ferris J, Francis C, Dunn M. 2023c. “They sent it away for testing and it was all bunk”: exploring perspectives on drug checking among steroid consumers in Queensland, Australia. Int J Drug Policy. 119:104139. doi: 10.1016/j.drugpo.2023.104139.
  • Piatkowski T, Robertson J, Dunn M. 2023d. Polysubstance use practices among women using anabolic-androgenic steroids (AAS). Perform Enhanc Health. 11(2):100248. doi: 10.1016/j.peh.2023.100248.
  • Pienaar K, Murphy DA, Race K, Lea T. 2020. Drugs as technologies of the self: enhancement and transformation in LGBAQ cultures. Int J Drug Policy. 78:102673. doi: 10.1016/j.drugpo.2020.102673.
  • Sagoe D, McVeigh J, Bjornebekk A, Essilfie MS, Andreassen CS, Pallesen S. 2015. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abuse Treat Prev Policy. 10(1):1–19. doi: 10.1186/s13011-015-0006-5.
  • Sagoe D, Pallesen S. 2018. Androgen abuse epidemiology. Curr Opin Endocrinol Diabetes Obes. 25(3):185–194. doi: 10.1097/MED.0000000000000403.
  • Simons R. 1995. Control in an age of empowerment. Harv Bus Rev. 73(2):80–88.
  • Sjöqvist F, Garle M, Rane A. 2008. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet. 371(9627):1872–1882. doi: 10.1016/S0140-6736(08)60801-6.
  • Sothern M, Reid B. 2018. Placing the human in health geography. In: Crooks V, Andrews GJ, Pearce J, editors. Routledge handbook in health geography. New York: Routledge.
  • Sparkes AC, Smith B. 2014. Qualitative research methods in sport, exercise and health: from process to product. London: Routledge.
  • Terry PC, Bertollo M. 2020. Advancement in mental skills training: an introduction. In: Bertollo M, Filho E, Terry P, editors. Advancements in Mental Skills Training. 1st ed. Routledge. doi: 10.4324/9780429025112
  • van Amsterdam J, Opperhuizen A, Hartgens F. 2010. Adverse health effects of anabolic–androgenic steroids. Regul Toxicol Pharmacol. 57(1):117–123. doi: 10.1016/j.yrtph.2010.02.001.
  • Zampini GF, Buck-Matthews E, Killick A, Salter L. 2021. We, ourselves and us: tensions of identity, intersubjectivity and positionality stemming from the people and dancefloors project. Int J Drug Policy. 98:103096. doi: 10.1016/j.drugpo.2020.103096.